TriLink | GenomeWeb

TriLink

NEW YORK (GenomeWeb) — New England Biolabs will supply RNA synthesis reagents to TriLink Biotechnologies under an agreement announced by the companies today.

Researchers at the University of North Texas Health Science Center recently developed an assay capable of quantifying nuclear DNA, mitochondrial DNA copy number, and the ratio of age-related deletions in the mitochondrial genome, in a single qPCR.

NEW YORK (GenomeWeb News) – Trilink BioTechnologies said today that it has inked a new licensing agreement with Biofortuna allowing the UK firm to use Trilink's hot start deoxynucleotides for freeze-drying molecular diagnostic kit development and production service.

TriLink Biotechnologies this week launched MitoPrimers for mitochondrial DNA PCR amplification and sequencing in forensic identification.

TriLink Biotechnologies said today that it has inked a licensing agreement with Denmark's QuantiBact to offer twisted intercalating nucleic acid, or TINA, modified oligonucleotides.

NEW YORK (GenomeWeb News) – TriLink BioTechnologies announced today a licensing deal with QuantiBact to offer twisted intercalating nucleic acid, or TINA, modified oligos.

NEW YORK (GenomeWeb News) – TriLink BioTechnologies today announced a $130,000 award from the National Institutes of Health to develop a sample preparation method for next-generation sequencing.

The Mayo Foundation for Medical Education and Research has been awarded US Patent No. 8,362,227, "Detection of Clostridium difficile."
Franklin Cockerill, Thomas Smith, Jon Rosenblatt, and Lynne Sloan are named as inventors.

NEW YORK (GenomeWeb News) – TriLink BioTechnologies said today that it has inked a licensing deal with Li-Cor Biosciences covering labeling of nucleic acids with near-infrared dyes.

This story has been updated from a previously posted version.
Enzo Diagnostics has been awarded US Patent No. 8,133,989, "Nucleic acid primer/construct compositions."

Pages

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.